HCPCS Level II · Drugs administered other than oral method
J2930Injection, methylprednisolone sodium succinate, up to 125 mg
Terminated 03/31/2024
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J2930
J2930 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, methylprednisolone sodium succinate, up to 125 mg.
It was added to HCPCS effective 01/01/1984, and its current record took effect 04/01/2024.
It was terminated on 03/31/2024 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Methylprednisolone injection
- Date added
- 01/01/1984
- Action effective
- 04/01/2024
- Termination date
- 03/31/2024
- BETOS
- O1E
Related J29xx codes
- J2916Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg
- J2919Injection, methylprednisolone sodium succinate, 5 mg
- J2941Injection, somatropin, 1 mg
- J2950Injection, promazine hcl, up to 25 mg
- J2993Injection, reteplase, 18.1 mg
- J2997Injection, alteplase recombinant, 1 mg
- J2998Injection, plasminogen, human-tvmh, 1 mg
Common questions about J2930
Is HCPCS J2930 still valid?
- No. J2930 was terminated on 03/31/2024.
Does Medicare cover J2930?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.